Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by type
6.1 Sterilization & Disinfectant Equipment
6.2 Disposable Hospital Supplies
6.3 Mobility Aids & Transportation Equipment
6.4 Patient Examination Devices
6.5 Operating Room Equipment
Chapter 7 Market Segmentation by geography
7.1 Australia
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Strategies Adopted By Top Companies
8.3 Market Share Analysis
Chapter 9 Company Profiles
9.1 Solvay Pharmaceuticals
9.1.1 Introduction
9.1.2 Company overview
9.1.3 Financial Performance
9.1.4 Product Benchmarking
9.2 Parke Davis Pty Ltd
9.3 Organon Australia Pty Ltd
9.4 Novo Nordisk Pharmaceuticals Pty Ltd
9.5 Otsuka Pharmaceutical Australia Pty Ltd
9.6 Reckitt & Colman Pharmaceuticals
9.7 Pfizer Pty Ltd
9.8 Rhone-Poulenc Rorer Australia Pty Ltd
9.9 Novartis Pharmaceuticals Australia Pty Ltd
9.10 Schering Pty Ltd
9.11 Schering-Plough Pty Ltd
9.12 Roche Products Pty Ltd
9.13 Sanofi-Synthelabo Australia Pty Limited
9.14 REM SYSTEMS Pty Ltd
9.15 RP Scherer Holdings Pty Ltd
9.16 Serono Australia Pty Ltd
9.17 Searle - A Division of Monsanto Australia Ltd
9.18 Smith & Nephew Pty Ltd
9.19 Sigma Pharmaceuticals Pty Ltd
Chapter 10 Market Estimates and Forecast
10.1 Market Estimation and Forecast 2018-2024(USD Billion)
10.1.1 Market Estimates and Forecast by type 2018-2024 (USD Billion)
10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Billion)
Chapter 11 Market Insights
11.1 Insights of Industry Experts
11.2 Investment Opportunities
11.3 Analyst Opinion
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
